학술논문
Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer
Document Type
Article
Author
Source
In: Clinical Drug Investigation . (Clinical Drug Investigation, 1 November 2018, 38(11):1071-1075)
Subject
Language
English
ISSN
11791918
11732563
11732563